G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/566 (2006.01)
Patent
CA 2589135
The present invention relates to the monitoring of disease progression and diagnosis of Insulin Resistance in diabetes by measuring levels of CD99 in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.
La présente invention concerne le suivi de la progression de la maladie et le diagnostic de la résistance insulinique du diabète par la mesure des niveaux de CD99 dans un prélèvement de liquide, et le classement des nouveaux composés destinés à la prévention et/ou au traitement du diabète.
Berndt Peter
Evers Stefan
Foser Stefan
Fountoulakis Michael
Martin Mitchell Lee
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Cd99 as target/marker for insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cd99 as target/marker for insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd99 as target/marker for insulin resistance will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1936336